Pediatrix Medical Group, Inc. (MD) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $22.61. It has a SharesGrow Score of 44/100, indicating a mixed investment profile with 0 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of MD = $46.10 (+103.9% from the current price, the stock appears undervalued). Analyst consensus target is MD = $21 (-8.6% upside).
Valuation: MD trades at a trailing Price-to-Earnings (P/E) of 10.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.67.
Financials: revenue is $1.9B, -1%/yr average growth. Net income is $165M, growing at +4%/yr. Net profit margin is 8.6% (thin). Gross margin is 24.7% (+1 pp trend).
Balance sheet: total debt is $660M against $866M equity (Debt-to-Equity (D/E) ratio 0.76, moderate). Current ratio is 1.66 (strong liquidity). Debt-to-assets is 29.4%. Total assets: $2.2B.
Analyst outlook: 14 / 33 analysts rate MD as buy (42%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 43/100 (Partial), Growth 30/100 (Fail), Past 50/100 (Partial), Health 67/100 (Partial), Moat 49/100 (Partial), Future 26/100 (Fail), Income 45/100 (Partial).
